
Sign up to save your podcasts
Or
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.
Learn:
Weight loss and glycemic differences between tirzepatide and semaglutide
What the FDA is thinking for compounded GLP-1s
If you're not on Dr. Spencer's virtual clinic waitlist, click here
4.7
361361 ratings
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.
Learn:
Weight loss and glycemic differences between tirzepatide and semaglutide
What the FDA is thinking for compounded GLP-1s
If you're not on Dr. Spencer's virtual clinic waitlist, click here
3,694 Listeners
1,203 Listeners
339 Listeners
46 Listeners
76 Listeners
517 Listeners
1,629 Listeners
1,140 Listeners
78 Listeners
208 Listeners
183 Listeners
101 Listeners
242 Listeners
52 Listeners